Company profile
Seres Therapeutics company profile
Seres Therapeutics develops and delivers therapies composed of live bacterial consortia that aim to modulate the human gut microbiome for therapeutic benefit. The company’s platform draws on insights into microbial ecology, host immune function, and gut barrier integrity to create oral treatments that act via multiple biological pathways. Its pipeline includes products designed to prevent infectious complications and antimicrobial-resistant bloodstream infections in vulnerable patient populations, as well as treatments for inflammatory and immune-related gastrointestinal disorders. Seres translates microbiome research into clinical development, manufacture, and commercialization of these novel live biotherapeutic medicines.
Business identity
- Contact email
- [email protected]
- Phone number
- +1 617 945 9626
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $10M-$100M
- Founded
- 2010-01-01, Year
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02139
- Country code
- US
- Continent
- North America